OBGC
JNJ icon

O'Brien Greene & Co’s Johnson & Johnson JNJ Stock Holding History

O'Brien Greene & Co’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Hold
6,296
– – 0.44% 41
2025
Q4 		$1.3M Sell
6,296
-50
-0.8% -$9.89K 0.39% 47
2025
Q3 		$1.18M Sell
6,346
-112
-2% -$19.2K 0.36% 48
2025
Q2 		$986K Sell
6,458
-400
-6% -$61.5K 0.32% 49
2025
Q1 		$1.14M Sell
6,858
-50
-0.7% -$7.82K 0.38% 49
2024
Q4 		$999K Sell
6,908
-88
-1% -$13.6K 0.32% 57
2024
Q3 		$1.13M Sell
6,996
-2,571
-27% -$410K 0.35% 52
2024
Q2 		$1.4M Buy
9,567
+797
+9% +$119K 0.44% 45
2024
Q1 		$1.39M Hold
8,770
– – 0.46% 45
2023
Q4 		$1.37M Hold
8,770
– – 0.48% 41
2023
Q3 		$1.37M Hold
8,770
– – 0.5% 42
2023
Q2 		$1.45M Hold
8,770
– – 0.5% 40
2023
Q1 		$1.36M Hold
8,770
– – 0.51% 41
2022
Q4 		$1.55M Sell
8,770
-18,236
-68% -$3.15M 0.59% 41
2022
Q3 		$4.41M Buy
27,006
+18,003
+200% +$3.05M 0.58% 41
2022
Q2 		$1.6M Sell
9,003
-258
-3% -$46K 0.6% 41
2022
Q1 		$1.64M Sell
9,261
-512
-5% -$87.1K 0.54% 41
2021
Q4 		$1.67M Sell
9,773
-377
-4% -$61.7K 0.55% 40
2021
Q3 		$1.64M Sell
10,150
-26,628
-72% -$4.54M 0.6% 39
2021
Q2 		$6.06M Buy
36,778
+1,570
+4% +$260K 2.16% 14
2021
Q1 		$5.79M Buy
35,208
+726
+2% +$117K 2.29% 16
2020
Q4 		$5.43M Buy
34,482
+2,695
+8% +$398K 2.23% 15
2020
Q3 		$4.73M Sell
31,787
-194
-0.6% -$28.7K 2.25% 16
2020
Q2 		$4.5M Sell
31,981
-238
-0.7% -$34.7K 2.38% 14
2020
Q1 		$4.22M Sell
32,219
-120
-0.4% -$17K 2.81% 11
2019
Q4 		$4.72M Sell
32,339
-1,830
-5% -$248K 2.4% 12
2019
Q3 		$4.42M Sell
34,169
-1,660
-5% -$219K 2.37% 12
2019
Q2 		$4.99M Sell
35,829
-287
-0.8% -$39.7K 2.62% 9
2019
Q1 		$5.05M Sell
36,116
-65
-0.2% -$8.71K 2.55% 9
2018
Q4 		$4.67M Buy
+36,181
New +$5.05M 2.78% 6

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

O'Brien Greene & Co's JNJ Position: Q1 2026 in Review

O'Brien Greene & Co held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 6,296 shares worth $1.54M. The position accounts for 0.44% of the portfolio, ranked #41.

O'Brien Greene & Co first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.06M in Q2 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • O'Brien Greene & Co held 6,296 shares of Johnson & Johnson worth $1.54M as of Q1 2026.
  • O'Brien Greene & Co left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.44% of O'Brien Greene & Co's portfolio in Q1 2026, its #41 holding.
  • O'Brien Greene & Co first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • O'Brien Greene & Co's Johnson & Johnson position peaked at $6.06M in Q2 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.